'25 at 25': Improving prostate cancer diagnosis
As part of our ‘
25 at 25’ series, highlighting 25 achievements of the MRC Clinical Trials Unit at UCL from the last 25 years, we look at how the PROMIS study has improved how prostate cancer is diagno…
'25 at 25': Patient and Public Involvement (PPI)
For almost two decades, the MRC Clinical Trials Unit at UCL has been committed to actively involving patients and the public in all our clinical trials and studies. As part of our ‘
25 at 25’ series to…
'25 at 25': PROUD - preventing HIV infections
...remarkable success of this study, as part of our ’
25 at 25’ series celebrating the MRC Clinical Trials Unit’s 25th anniversary.
PROUD was the first study of the pre-exposure prophylaxis approach t…
'25 at 25': Shortening treatment for tuberculosis
A long road to recovery lies ahead for people diagnosed with tuberculosis (TB). Treatments lasting several months can be tough for patients due to challenging side effects, the burden of daily medicat…
'25 at 25': The PRACTical trial design
As part of the MRC Clinical Trials Unit at UCL’s 25th anniversary celebrations, we highlight the Unit’s role in developing new clinical trial designs to address problems where standard trial designs a…
'25 at 25': Training and capacity strengthening
Capacity strengthening is at the core of our clinical trials and methodology work, aiming to enhance the skills of trial teams we work with across the globe, so they can deliver their own sustainable,…